Keywords
prevention
therapeutic options
treatment
elderly
How to Cite
Abstract
Background. Frailty syndrome is very important in assessing the course of the aging process, as it has long-term health implications. The group of major international scientists defined physical frailty as “a medical syndrome with multiple causes and contributors that is characterized by diminished strength, endurance, and reduced physiologic function that increases an individual’s vulnerability for developing increased dependency and/or death”. Objectives. The aim of the study was to analyze the literature and collect the most important information on the prevention and treatment of the frailty syndrome. Discussion. Frailty syndrome is still a studied and diagnosed affliction. Recent recommendations and therapeutic options are not gathered in any guidelines so far, due to the fact there is not enough research on a dedicated group. However, many scientists and researchers report that early diagnosis, physical activity and a change in eating habits can have a positive effect on further prognoses. It is important to make every effort in the diagnosis of the elderly towards the frailty syndrome. As a result, early diagnosis allows for longer independence of the patient and the possibility of ensuring care. A care model that focuses on health promotion and disease prevention can influence decision making and care planning for older people. Conclusions. 1. Physical activity can potentially prevent and reduce the risk of frailty syndrome. 2. A properly selected diet can relieve the course of frailty syndrome. 3. Monitoring micro and macro levels of elements and blood parameters, hormones help to control the course of frailty syndrome. 4. Early diagnosis and the resulting preventive measures can significantly reduce the incidence of frailty syndrome among the elderly. 5. Adequate care of the primary care giver is able to provide the patient with a better prognosis.References
Gulliford M, Ravindrarajah R. Frailty: from clinical syndrome to epidemiological construct? Lancet Public Health 2018; 3(7): e305– –e306.
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56(3): M146–M157.
Morley JE, Vellas B, Abellan van Kan G, et al. Frailty consensus: a call to action. J Am Med Dir Assoc 2013; 14(6): 392–397.
Wleklik M, Uchmanowicz I. Tilburg Frailty Indicator – simple research tool to identify patients with Frailty Syndrome. Wsp Piel Ochr Zdr 2015; 4(4): 82–85.
Panza F, Lozupone M, Solfrizzi V, et al. Different cognitive frailty models and health- and cognitive-related outcomes in older age: from epidemiology to prevention. J Alzheimers Dis 2018; 62(3): 993–1012.
Życzkowska J, Grądalski T. Frailty – an overview for oncologists. Onkol Prak Klin 2010; 6(2): 79–84.
Łęgosz P, Krzowski B, Ryś A, i wsp. Zespół kruchości w gabinecie lekarza praktyka – o czym należy pamiętać? Folia Cardiol 2018; 2(3): 222–228.
Gabryś T, Bajorek A, Malinowska-Lipień I. The Frailty Syndrome – a major health problem of the elderly people. Part I. Gerontol Pol 2015; 1: 29–33.
Kane AE, Gregson E, Theou O, et al. The association between frailty, the metabolic syndrome, and mortality over the lifespan. GeroScience 2017; 39(2): 221–229.
Castell M-V, Sánchez M, Julián R, et al. Frailty prevalence and slow walking speed in persons age 65 and older: implications for primary care. BMC Fam Pract 2013; 14(1): 86.
Carneiro JA, Cardoso RR, Durães MS, et al. Frailty in the elderly: prevalence and associated factors. Rev Bras Enferm 2017; 70(4): 747–752.
Satake S, Arai H. Chapter 1 Frailty: definition, diagnosis, epidemiology. Geriatr Gerontol Int 2020; 20(S1): 7–13.
Labra C de, Guimaraes-Pinheiro C, Maseda A, et al. Effects of physical exercise interventions in frail older adults: a systematic review of randomized controlled trials. BMC Geriatr 2015; 15(1): 154.
Woolford SJ, Sohan O, Dennison EM, et al. Approaches to the diagnosis and prevention of frailty. Aging Clin Exp Res 2020; 32(9): 1629–1637.
Rossi PG, Carnavale BF, Farche ACS, et al. Effects of physical exercise on the cognition of older adults with frailty syndrome: a systematic review and meta-analysis of randomized trials. Arch Gerontol Geriatr 2021; 93: 104322.
Dziubek W, Pawlaczyk W, Stefańska M, et al. Evaluation of psychophysical factors in individuals with frailty syndrome following a 3-month controlled physical activity program. Int J Environ Res Public Health 2020; 17(21): 7804.
Gutiérrez-Valencia M, Izquierdo M, Cesari M, et al. The relationship between frailty and polypharmacy in older people: a systematic review: frailty and polypharmacy: a systematic review. Br J Clin Pharmacol 2018; 84(7): 1432–1444.
Palliyaguru DL, Moats JM, Di Germanio C, et al. Frailty index as a biomarker of lifespan and healthspan: focus on pharmacological interventions. Mech Ageing Dev 2019; 180: 42–48.
How polypharmacy affects frailty Available from URL: https:// www.tandfonline.com/doi/full/10.1080/17512433.2020.182946 7 [cyt. 28.08.2021].
Integrated care for older people (ICOPE): guidance for person- -centred assessment and pathways in primary care. Available from URL: https://www.who.int/publications-detail-redirect/ WHO-FWC-ALC-19.1 [cyt. 28.08.2021].
Piejko L, Nawrat-Szołtysik A. Możliwości terapii zespołu kruchości u osób starszych. Geriatria 2017; 11 : 283–289.
Baptista LC, Sun Y, Carter CS, et al. Crosstalk between the gut microbiome and bioactive lipids: therapeutic targets in cognitive frailty. Front Nutr 2020; 7: 17.
Schoufour JD, Overdevest E, Weijs PJM, et al. Dietary protein, exercise, and frailty domains. Nutrients 2019; 11(10): 2399.
Talegawkar SA, Bandinelli S, Bandeen-Roche K, et al. A higher adherence to a mediterranean-style diet is inversely associated with the development of frailty in community-dwelling elderly men and women. J Nutr 2012; 142(12): 2161–2166.
Clegg A, Hassan-Smith Z. Frailty and the endocrine system. Lancet Diabetes Endocrinol 2018; 6(9): 743–752.
Singh M, Stewart R, White H. Importance of frailty in patients with cardiovascular disease. Eur Heart J 2014; 35(26): 1726–1731.
Dent E, Lien C, Lim WS, et al. The Asia-Pacific clinical practice guidelines for the management of frailty. J Am Med Dir Assoc 2017; 18(7): 564–575.
Zhou J, Huang P, Liu P, et al. Association of vitamin D deficiency and frailty: a systematic review and meta-analysis. Maturitas 2016; 94: 70–76.
Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37(29): 2315–2381.
Frontkiewicz D, Zawadzki B, Bogusiak M, et al. What is frailty syndrome in patients with heart failure. Gerontol Pol 2018; 26(1): 209–213.
Uchmanowicz I. The influence of frailty syndrome on the assessment of illness acceptance in elderly patients with chronic heart failure. Gerontol Pol 2015; 1: 3–10.
Davis MR, Lee CS, Corcoran A, et al. Gender differences in the prevalence of frailty in heart failure: a systematic review and meta- -analysis. Int J Cardiol 2021; 333: 133–140.
Uchmanowicz I, Lee CS, Vitale C, et al. Frailty and the risk of all- -cause mortality and hospitalization in chronic heart failure: a meta-analysis. ESC Heart Fail 2020; 7(6): 3427–3437.
Ma Y, Hou L, Yang X, et al. The association between frailty and severe disease among COVID-19 patients aged over 60 years in China: a prospective cohort study. BMC Med 2020; 18: 274.
Woolford SJ, D’Angelo S, Curtis EM, et al. COVID-19 and associations with frailty and multimorbidity: a prospective analysis of UK Biobank participants. Aging Clin Exp Res 2020; 32(9): 1897–1905.
Hägg S, Jylhävä J, Wang Y, et al. Age, frailty, and comorbidity as prognostic factors for short-term outcomes in patients with coronavirus disease 2019 in geriatric care. J Am Med Dir Assoc 2020; 21(11): 1555–1559.
Kundi H, Çetin EHÖ, Canpolat U, et al. The role of frailty on adverse outcomes among older patients with COVID-19. J Infect 2020; 81(6): 944–851.
Walston J, Buta B, Xue Q-L. Frailty screening and interventions. Clin Geriatr Med 2018; 34(1): 25–38.
Cesari M, Prince M, Thiyagarajan JA, et al. Frailty: an emerging public health priority. J Am Med Dir Assoc 2016; 17(3): 188–192.
Miyamura K, Fhon JRS, Bueno A de, et al. Frailty syndrome and cognitive impairment in older adults: systematic review of the literature. Rev Lat Am Enfermagem 2019; 27: e3202.
Brummel NE, Bell SP, Girard TD, et al. Frailty and subsequent disability and mortality among patients with critical illness. Am J Respir Crit Care Med 2017; 196(1): 64–72.
Gabryś T, Bajorek A, Malinowska-Lipień I. The Frailty Syndrome – a major health problem of the elderly people. Part II. Gerontol Pol 2015; 4: 165–170.